INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "HYDROQUINAZOLINE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER"

GENEVA, March 9 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/058660) for "HYDROQUINAZOLINE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER" on Aug 27, 2025. With publication no. WO/2026/047575, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANGST, Daniela (Novartis Pharma AGLichtstrasse 354056 Basel), BOLDUC, Philippe (324 East St.Weymouth, Massachusetts 02189), CARSON, Matthew William (Novartis Institutes for BioMedical Research, Inc.250 Massachusetts AvenueCambridge, Massachu...